Fig. 1: Overview of the discovery cohort selection process.
From: Proteomic characterization of acute kidney injury in patients hospitalized with SARS-CoV2 infection

a Cohort selection strategy overview. (abbreviation legend: AKI Acute Kidney Injury, ESKD End Stage Kidney Disease, Ctrls Controls) b Estimated Glomerular Filtration Rate (eGFR) measurements recorded post-discharge for returning patients until 12/21/2021. Source data for a are generated from Supplementary Data 3, which is in turn generated from the clinical data table in the Synapse data repository syn35874390.